双歧杆菌对坏死性小肠结肠炎新生大鼠肠道&beta;-防御素-2表达的影响

卢维城; 郑旭; 刘金富; 吴文川; 陈兴月; 魏海波; 李春蕾; 林明静

doi:10.7499/j.issn.1008-8830.2018.03.012

PDF(1666 KB)

HTML

中国当代儿科杂志 ›› 2018, Vol. 20 ›› Issue (3) : 224-229. DOI: 10.7499/j.issn.1008-8830.2018.03.012

论著·实验研究

双歧杆菌对坏死性小肠结肠炎新生大鼠肠道β-防御素-2表达的影响

卢维城¹, 郑旭¹, 刘金富², 吴文川², 陈兴月¹, 魏海波¹, 李春蕾¹, 林明静¹

作者信息 +

Effect of Bifidobacterium on the expression of β-defensin-2 in intestinal tissue of neonatal rats with necrotizing enterocolitis

LU Wei-Cheng¹, ZHENG Xu¹, LIU Jin-Fu², WU Wen-Chuan², CHEN Xing-Yue¹, WEI Hai-Bo¹, LI Chun-Lei¹, LIN Ming-Jing¹

Author information +

文章历史 +

摘要

目的探讨双歧杆菌对坏死性小肠结肠炎（NEC）新生大鼠肠道β-防御素-2（BD-2）表达的影响。方法将40只大鼠分为正常对照组、双歧杆菌对照组、NEC模型组和双歧杆菌干预组（n=10）。采用缺氧+冷刺激+人工喂养的方法建立NEC模型。双歧杆菌对照组和双歧杆菌干预组在每日冷刺激后经胃管注入双歧杆菌，每天1次，连续3 d。收集各组大鼠末段回肠组织于光镜下观察形态学改变并对肠道损伤进行评分，采用免疫组织化学法、qRT-PCR法分别检测各组大鼠回肠黏膜组织中BD-2蛋白及mRNA的表达水平。结果 NEC模型组肠道损伤评分分别高于正常对照组、双歧杆菌对照组、双歧杆菌干预组（P < 0.05）；双歧杆菌干预组的肠道损伤评分高于正常对照组和双歧杆菌对照组（P < 0.05）。正常对照组BD-2 mRNA及蛋白的表达低于双歧杆菌对照组、NEC模型组和双歧杆菌干预组（P < 0.05）；双歧杆菌对照组BD-2 mRNA及蛋白的表达高于NEC模型组和双歧杆菌干预组（P < 0.05）；双歧杆菌干预组BD-2 mRNA及蛋白的表达高于NEC模型组（P < 0.05）。结论双歧杆菌可诱导大鼠肠道表达BD-2，其可能通过增加BD-2的表达而减轻肠道炎症反应，发挥对新生大鼠NEC模型的保护作用。

Abstract

Objective To study the effect of Bifidobacterium on the expression of β-defensin-2 (BD-2) in intestinal tissue of neonatal rats with necrotizing enterocolitis (NEC). Methods A total of 40 rats were randomly divided into four groups:normal control, Bifidobacterium control, NEC model, and Bifidobacterium treatment, with 10 rats in each group. A rat model of NEC was induced by hypoxia, cold stimulation, and artificial feeding. The rats in the Bifidobacterium control and Bifidobacterium treatment groups were given Bifidobacterium via the gastric tube after cold stimulation once a day for three consecutive days. The morphological changes of the terminal ileum were observed under a light microscope and the intestinal injury score was determined. Immunohistochemistry and qRT-PCR were used to measure the protein and mRNA expression of BD-2 in the ileal mucosal tissue. Results The NEC model group had a significantly higher intestinal injury score than the normal control, Bifidobacterium control, and Bifidobacterium treatment groups (P < 0.05). The Bifidobacterium treatment group had a significantly higher intestinal injury score than the normal control and Bifidobacterium control groups (P < 0.05). The mRNA and protein expression of BD-2 in the normal control group was significantly lower than in the Bifidobacterium control, NEC model, and Bifidobacterium treatment groups (P < 0.05). The Bifidobacterium control group had significantly higher mRNA and protein expression of BD-2 than the NEC model and Bifidobacterium treatment groups (P < 0.05). The Bifidobacterium treatment group had significantly higher mRNA and protein expression of BD-2 than the NEC model group (P < 0.05). Conclusions Bifidobacterium can induce the expression of BD-2 in intestinal tissue of rats and reduce inflammatory response by increasing the expression of BD-2. This provides a protective effect on neonatal rats with NEC.

导出引用

卢维城, 郑旭, 刘金富, 吴文川, 陈兴月, 魏海波, 李春蕾, 林明静. 双歧杆菌对坏死性小肠结肠炎新生大鼠肠道β-防御素-2表达的影响[J]. 中国当代儿科杂志. 2018, 20(3): 224-229 https://doi.org/10.7499/j.issn.1008-8830.2018.03.012

LU Wei-Cheng, ZHENG Xu, LIU Jin-Fu, WU Wen-Chuan, CHEN Xing-Yue, WEI Hai-Bo, LI Chun-Lei, LIN Ming-Jing. Effect of Bifidobacterium on the expression of β-defensin-2 in intestinal tissue of neonatal rats with necrotizing enterocolitis[J]. Chinese Journal of Contemporary Pediatrics. 2018, 20(3): 224-229 https://doi.org/10.7499/j.issn.1008-8830.2018.03.012

参考文献

[1] Neu J, Walker WA. Necrotizing enterocolitis[J]. N Engl J Med, 2011, 364(3):255-264.
[2] Halpern MD, Denning PW. The role of intestinal epithelial barrier function in the development of NEC[J]. Tissue Barriers, 2015, 3(1-2):e1000707.
[3] Kim MJ, Lee WY, Choe YH. Expression of TIM-3, human β-defensin-2, and FOXP3 and correlation with disease activity in pediatric Crohn's disease with infliximab therapy[J]. Gut Liver, 2015, 9(3):370-380.
[4] Underwood MA. Probiotics and innate and adaptive immune responses in premature infants[J]. For Immunopathol Dis Therap, 2016, 7(1-2):1-15.
[5] Costeloe K, Hardy P, Juszczak E, et al. Bifidobacterium breve BBG-001 in very preterm infants:a randomized controlled phase 3 trial[J]. Lancet, 2016, 387(10019):649-660.
[6] AlFaleh K, Anabrees J. Probiotics for prevention of necrotizing enterocolitis in preterm infants[J]. Evid Based Child Health, 2014, 9(3):584-671.
[7] 盛庆丰, 吕志葆, 蔡威, 等. 重组人β-防御素3干预新生大鼠坏死性小肠结肠炎模型的研究[J]. 中华小儿外科杂志, 2015, 36(2):109-112.
[8] Nadler EP, Dickinson E, Knisely A, et al. Expression of inducible nitric oxide synthase and interleukin-12 in experimental necrotizing enterocolitis[J]. J Surg Res, 2000, 92(1):71-77.
[9] Birner P, Schindl M, Obermair A, et al. Overexpression of hypoxia-inducible factor 1 alpha is a marker for an unfavorable prognosis in early-stage invasive cervical cancer[J]. Cancer Res, 2000, 60(17):4693-4696.
[10] 何彦册, 贺湘英, 黄永坤, 等. 酪酸梭菌对坏死性小肠结肠炎新生鼠肠损伤的保护作用[J]. 临床儿科杂志, 2016, 34(7):547-552.
[11] Denning TL, Bhatia AM, Kane AF, et al. Pathogenesis of NEC:Role of the innate and adaptive immune response[J]. Semin Perinatol, 2017, 41(1):15-28.
[12] Battersby AJ, Khara J, Wright VJ, et al. Antimicrobial proteins and peptides in early life:ontogeny and translational opportunities[J]. Front Immunol, 2016, 7:309.
[13] Weitkamp JH, Koyama T, Rock MT, et al. Necrotising enterocolitis is characterised by disrupted immune regulation and diminished mucosal regulatory (FOXP3)/effector (CD4, CD8) T cell ratios[J]. Gut, 2013, 62(1):73-82.
[14] Trend S, Strunk T, Hibbert J, et al. Antimicrobial protein and Peptide concentrations and activity in human breast milk consumed by preterm infants at risk of late-onset neonatal sepsis[J]. PLoS One, 2015, 10(2):e0117038.
[15] Olbrich P, Pavón A, Rosso ML, et al. Association of human beta-defensin-2 serum levels and sepsis in preterm neonates[J]. Pediatr Crit Care Med, 2013, 14(8):796-800.
[16] Richter M, Topf HG, Gröschl M, et al. Influence of gestational age, cesarean section, and type of feeding on fecal human beta-defensin 2 and tumor necrosis factor-alpha[J]. J Pediatr Gastroenterol Nutr, 2010, 51(1):103-105.
[17] Campeotto F, Baldassarre M, Laforgia N, et al. Fecal expression of human β-defensin-2 following birth[J]. Neonatology, 2010, 98(4):365-369.
[18] Jenke AC, Zilbauer M, Postberg J, et al. Human β-defensin 2 expression in ELBW infants with severe necrotizing enterocolitis[J]. Pediatr Res, 2012, 72(5):513-520.
[19] Patel RM, Denning PW. Intestinal microbiota and its relationship with necrotizing enterocolitis[J]. Pediatr Res, 2015, 78(3):232-238.
[20] 郭城, 张琳. 益生菌在新生儿坏死性小肠结肠炎中的应用[J]. 中国实用儿科杂志, 2017, 32(2):120-125.
[21] Jenke AC, Postberg J, Mariel B, et al. S100A12 and hBD2 correlate with the composition of the fecal microflora in ELBW infants and expansion of E. coli is associated with NEC[J]. Biomed Res Int, 2013, 2013:150372.
[22] 李阳, 余加林, 艾青, 等. 早产儿坏死性小肠结肠炎肠道菌群多样性及其动态研究[J]. 中国循证儿科杂志, 2014, 9(2):117-121.
[23] Habil N, Abate W, Beal J, et al. Heat-killed probiotic bacteria differentially regulate colonic epithelial cell production of human β-defensin-2:dependence on inflammatory cytokines[J]. Beneficial Microbes, 2014, 5(4):483-495.
[24] Yoon YM, Lee JY, Yoo D, et al. Bacteroides fragilis enterotoxin induces human beta-defensin-2 expression in intestinal epithelial cells via a mitogen-activated protein kinase/I kappaB kinase/NF-kappaB-dependent pathway[J]. Infect Immun, 2010, 78(5):2024-2033.
[25] Lewis SB, Prior A, Ellis SJ, et al. Flagellin induces β-defensin 2 in human colonic Ex vivo infection with enterohemorrhagic Escherichia coli[J]. Front Cell Infect Microbiol, 2016, 6:68.
[26] Omagari D, Takenouchi-Ohkubo N, Endo S, et al. Nuclear factor kappa B plays a pivotal role in polyinosinic-polycytidylic acid-induced expression of human β-defensin 2 in intestinal epithelial cells[J]. Clin Exp Immunol, 2011, 165(1):85-93.